Filing Details
- Accession Number:
- 0001415889-24-024676
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-03 19:03:40
- Reporting Period:
- 2024-10-02
- Accepted Time:
- 2024-10-03 19:03:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1422142 | Aadi Bioscience Inc. | AADI | Pharmaceutical Preparations (2834) | 611547850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1995275 | James David Lennon | C/O Aadi Bioscience, Inc. 17383 Sunset Boulevard, Suite A250 Pacific Palisades CA 90272 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-02 | 32,558 | $0.00 | 32,558 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-10-03 | 9,689 | $1.94 | 22,869 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Units | Disposition | 2024-10-02 | 32,558 | $0.00 | 32,558 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024.